4-(4-(Hydroxymethyl)piperidin-1-yl)benzaldehyde, 98%, 1g

6-Chloro-7-hydroxy-4-methylcoumarin>98.0%(GC)5g

Ethyl 3-bromophenylacetate, 95.0%, 100g

Ethyl 2-(3-chloro-2-fluoro-phenoxy)acetate, 97.0%, 1g

1-PYRROLIDINECARBOXYLIC ACID, 3-AMINO-4-(4-FLUOROPHENYL)-, 1,1-DIMETHYLETHYL ESTER, (3R,4R)-REL-, 95.0%, 250mg

2,4-Dibromo-1-methoxynaphthalene, 95+%, 1g

tert-Butyl 6-Bromo-1H-indazole-1-carboxylate, 97.0%, 1g

tert-Butyl 2-(methylthio)-4-(((trifluoromethyl)sulfonyl)oxy)-5,8-dihydropyrido[3,4-d]pyrimidine-7(6H)-carboxylate, 97%, 10g

8-Chloro-2-methyl-1-octene, 95.0%, 2g

4-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid, 97.0%, 5g

tert-Butyl (4-(S-methylsulfonimidoyl)phenyl)carbamate, 100mg

TLC Plates SIL G-25 / UV254, 2,5 x 7,5 cm, 100 Piece(s)

Anti-GT1a Monoclonal Antibody1vial